Skip to content

Effects of exercise on hematological and imaging indexes of myocardial fibrosis in patients with myocardial infarction

Effects of exercise on hematological and imaging indexes of myocardial fibrosis in patients with myocardial infarction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056474
Enrollment
Unknown
Registered
2022-02-06
Start date
2022-01-24
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction

Interventions

Exercise group:Exercise training +Clinical Standardization of Secondary Prevention Drug Treatment for Coronary Heart Disease
Control group:Clinical Standardization of Secondary Prevention Drug Treatment for Coronary Heart Disease

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. Patients diagnosed with acute ST-segment elevation myocardial infarction within 3 months and the first onset according to clinical symptoms; 3. Informed and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1.Unstable angina pectoris; 2.Systolic blood pressure > 200 mmHg or diastolic blood pressure > 110 mmHg at rest, blood pressure drop > 20 mmHg after standing upright and accompanied by symptoms; 3.Severe aortic stenosis, acute systemic disease or fever, uncontrolled atrial or ventricular arrhythmia, uncontrolled sinus tachycardia (>120 beats/min); 4.Uncontrolled heart failure; 5.Third-degree atrioventricular block without a pacemaker; 6.Active pericarditis or myocarditis, thrombophlebitis, recent thromboembolism; 7.ST segment depression or elevation (>2 mm) at rest; 8.Severe motor system abnormalities that can limit exercise capacity and other metabolic abnormalities, such as acute thyroiditis, hypokalemia, hyperkalemia or hypovolemia.

Design outcomes

Primary

MeasureTime frame
T1 mapping;Extracellular volume;left ventricular ejection fraction;

Secondary

MeasureTime frame
Quality of Life;

Countries

China

Contacts

Public ContactDing Rongjing

Peking University People's Hospital

drj2003@vip.163.com+86 13552548612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026